People in the evaluation of uterine fibroids treatment efficacy, it is usually in order to improve the symptoms of an index, but the Monterey Peninsula of California Institute of Surgery Dr. Lee and others in their research
, With symptoms completely disappear as an index to evaluate the radio-frequency ablation (RFA) treatment.
The 58 cases included in the study (average age 46.9 years) for women suffering from uterine fibroids, which are usually women who want to retain the uterus or willing to accept out-patient surgery cases, their symptoms, including blood
Too much, dysmenorrhea, sexual difficulties, pelvic pressure, urinary frequency, pain and sleep disorders, uterine fibroids the size of 1 ~ 11 cm.
Researchers from the use of a RITA Medical Systems to expand the system implementation of needle electrodes RFA. After 1,3,6,9 and 12 months for patients with ultrasound and clinical assessment
. At present, 67% of patients received at least 6 months of follow-up, 46% of the patients received 1-year follow-up.
12 months, patients with too much blood, dysmenorrhea, sexual difficulties, pelvic pressure, urinary frequency of complete remission rates were 94%, 93%, 100%, 100% and 100%, In addition, local pain
Pain and sleep disorders of the complete remission rates were 50% and 94%.
For the equivalent of the size of the uterus before 10 weeks gestation or more women, RFA and reduce uterine volume related. The women's uterus in volume after 3 months to reduce the average 36% (P <0.
0001); 6 months to reduce the average 41% (P <0. 0001). No cases of relapse after treatment.
In early studies, 2 cases occurred in parts of the liner scalded skin, 1 case of umbilical trauma patients.
